Roka Bioscience Inc (ROKA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2016 | 12-2015 | 12-2014 | 12-2013 | 12-2012 | |
| Sales | 7,242 | 5,985 | 5,057 | 2,182 | 105 |
| Cost of Goods | 7,974 | 7,704 | 7,847 | 6,600 | 3,186 |
| Gross Profit | -732 | -1,719 | -2,790 | -4,418 | -3,081 |
| Operating Expenses | 29,724 | 34,279 | 29,649 | 25,819 | 25,990 |
| Operating Income | -29,482 | -35,294 | -31,592 | -29,637 | -28,885 |
| Interest Expense | 0 | 0 | 0 | 0 | 140 |
| Other Income | -1,550 | -2,006 | -2,590 | -3,033 | 4,996 |
| Pre-tax Income | -31,032 | -37,300 | -34,182 | -32,670 | -24,029 |
| Income Tax | -245 | -700 | -1,952 | -3,092 | -783 |
| Net Income Continuous | -30,787 | -36,600 | -32,230 | -29,578 | -23,246 |
| Net Income | $-30,787 | $-36,600 | $-32,230 | $-29,578 | $-23,246 |
| EPS Basic Total Ops | -17.42 | -21.18 | -29.30 | -568.10 | -705.40 |
| EPS Basic Continuous Ops | -13.92 | -21.18 | -29.30 | -568.81 | -704.42 |
| EPS Diluted Total Ops | -17.42 | -21.18 | -29.30 | -568.10 | -705.40 |
| EPS Diluted Continuous Ops | -13.92 | -21.18 | -29.30 | -568.81 | -704.42 |
| EPS Diluted Before Non-Recurring Items | -17.42 | -21.20 | -29.30 | -32.60 | N/A |
| EBITDA(a) | $-23,649 | $-28,711 | $-27,344 | $-27,200 | $-26,840 |